Action tremor control with deep brain stimulation in patients with Parkinson’s disease: Specific target associations
Objective: To determine the effects of deep brain stimulation (DBS) on action tremor in Parkinson’s disease (PD) and to identify if there are specific target…Wearable sensor-based therapy titration for Parkinson’s Disease
Objective: To describe a home-based method for improved Parkinson’s therapy titration. Background: Many patients with Parkinson’s disease, due to the location of their residence or…Closed Loop STN DBS for Tremor in Parkinson’s disease using a Neural or Kinematic Signal
Objective: Compare safety, tolerability, efficiency and efficacy of closed loop DBS (clDBS) of the subthalamic nucleus (STN) for resting tremor in Parkinson’s disease (PD) using…Ultrasonography-guided Botulinum Toxin Type-A Injection in Tremor. An open-label Study
Objective: To assess the role of ultrasound-guided (US) Onabotulinumtoxin-A (BoNT-A) injections for various types of hand and head tremor. Background: Focal treatment of head and…Cannabis and Parkinson’s Disease Tremor
Objective: The purpose of this study was to describe the effect of Cannabis on Parkinson’s disease (PD) tremor using advanced motion detection technology and qualitative…TETRAS applicability and study design in randomized, placebo controlled clinical trial of Cav3 modulation for essential tremor patients.
Objective: We will study CX-8998, a selective Cav3 antagonist with safety data in 194 patients, in the treatment of ET. Few large controlled ET trials…Comparison of the effect of thalamic DBS/coagulation on tremor and thalamic neuronal activity in spinocerebellar ataxia and essential tremor
Objective: To investigate the effects of deep brain stimulation (DBS) or lesions of the ventral intermediate nucleus (Vim) of the thalamus for spinocerebellar ataxia (SCA)…Efficacy and safety of incobotulinumtoxinA (inco/A) for essential tremor using kinematics-guided clinical decision support: A randomized, double-blind, placebo-controlled trial
Objective: To demonstrate improvement of arm tremor severity and hand function with kinematics-guided inco/A therapy Background: Botulinum neurotoxin A (BoNT-A) therapy of debilitating tremor symptoms…Open label study of cannabidiol in Parkinson disease
Objective: To determine if cannabidiol (CBD) is tolerated and effective in Parkinson disease (PD) and the dosage needed for a Phase 2 randomized controlled trial.…The occurrence of dopamine-responsive and dopamine-resistant resting tremor in Parkinson’s disease
Objective: To investigate dopamine-responsiveness of resting tremor in Parkinson’s disease Background: Unlike the core Parkinson motor symptom, bradykinesia, resting tremor has a variable response to…
- « Previous Page
- 1
- …
- 10
- 11
- 12
- 13
- 14
- 15
- Next Page »